Nacubactam Uses, Dosage, Side Effects and more
Nacubactam is under investigation in clinical trial NCT03174795 (A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection).
| Trade Name | Nacubactam |
| Generic | Nacubactam |
| Nacubactam Other Names | Nacubactam |
| Type | |
| Formula | C9H16N4O7S |
| Weight | Average: 324.31 Monoisotopic: 324.073970045 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
